Exploring the cellular activity of camptothecin-triple-helix-forming oligonucleotide conjugates.
about
Sequence-specific targeting of IGF-I and IGF-IR genes by camptothecinsMeganucleases and other tools for targeted genome engineering: perspectives and challenges for gene therapy.Single-molecule observations of topotecan-mediated TopIB activity at a unique DNA sequence.The triple helix: 50 years later, the outcome.DNA-binding drugs caught in action: the latest 3D pictures of drug-DNA complexes.Gene targeting from laboratory to livestock: current status and emerging concepts.Targeted approaches for gene therapy and the emergence of engineered meganucleases.Biological and cytoselective anticancer properties of copper(II)-polypyridyl complexes modulated by auxiliary methylated glycine ligand.[Zn(phen)(O,N,O)(H2O)] and [Zn(phen)(O,N)(H2O)] with O,N,O is 2,6-dipicolinate and N,O is L-threoninate: synthesis, characterization, and biomedical properties.DNA triplex formation with 5-dimethylaminopropargyl deoxyuridineTargeted gene correction using psoralen, chlorambucil and camptothecin conjugates of triplex forming peptide nucleic acid (PNA).Coupling the core of the anticancer drug etoposide to an oligonucleotide induces topoisomerase II-mediated cleavage at specific DNA sequences.The past and presence of gene targeting: from chemicals and DNA via proteins to RNA.DNA molecular recognition and cellular selectivity of anticancer metal(II) complexes of ethylenediaminediacetate and phenanthroline: multiple targets.
P2860
Q33533698-60C35BE4-CDB6-46C1-B549-DFC538B22B7CQ35701287-255E26C9-4773-4CD1-9CDB-C3D22BB68704Q36633210-08ED71D0-0917-4289-B47C-C7843B5AAFC1Q36868459-0BE2E8AD-0BB8-429F-B8A1-F47A982176CFQ37362257-66D7D764-BBDA-446A-9159-A4CBFA97165BQ37552793-C68BD958-BA2B-4E62-A28F-8213CB014C6BQ37581606-930BF746-A72A-4272-835C-76F0144DD6E1Q39307579-58CF8BE3-2D8D-4CAC-843C-AB49A24A8C13Q39309334-B41F85A3-A1C9-4DD7-B90A-DFD3DF169170Q42105925-D641C387-D37E-4431-ACE8-ABBA75A8EEE2Q42670312-4A4299C7-D846-4F24-A264-926A885991C4Q49977881-5980C4AA-A1FF-4E18-A988-DE4459055B26Q52431809-B2327463-1840-4903-B9AA-1761498D8820Q53226568-248926F1-81FF-4C5F-8FF3-248D7AD86B47
P2860
Exploring the cellular activity of camptothecin-triple-helix-forming oligonucleotide conjugates.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Exploring the cellular activit ...... ng oligonucleotide conjugates.
@ast
Exploring the cellular activit ...... ng oligonucleotide conjugates.
@en
type
label
Exploring the cellular activit ...... ng oligonucleotide conjugates.
@ast
Exploring the cellular activit ...... ng oligonucleotide conjugates.
@en
prefLabel
Exploring the cellular activit ...... ng oligonucleotide conjugates.
@ast
Exploring the cellular activit ...... ng oligonucleotide conjugates.
@en
P2093
P2860
P1476
Exploring the cellular activit ...... ng oligonucleotide conjugates.
@en
P2093
Amélie Lansiaux
Brigitte Baldeyrou
Carine Giovannangeli
Christian Bailly
Christine Mahieu
Craig J Thomas
Kahina Oussedik
Ludovic Halby
Paola B Arimondo
Sidney M Hecht
P2860
P304
P356
10.1128/MCB.26.1.324-333.2006
P407
P577
2006-01-01T00:00:00Z